Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis. 2016

Masashi Satoh, and Ken-Ichi Namba, and Nobuyoshi Kitaichi, and Noriko Endo, and Hirokuni Kitamei, and Daiju Iwata, and Shigeaki Ohno, and Susumu Ishida, and Kazunori Onoé, and Hiroshi Watarai, and Masaru Taniguchi, and Tatsuro Ishibashi, and Joan Stein-Streilein, and Koh-Hei Sonoda, and Luc Van Kaer, and Kazuya Iwabuchi
Department of Immunology, Kitasato University School of Medicine, Sagamihara, Japan.

Experimental autoimmune uveoretinitis (EAU) represents an experimental model for human endogenous uveitis, which is caused by Th1/Th17 cell-mediated inflammation. Natural killer T (NKT) cells recognize lipid antigens and produce large amounts of cytokines upon activation. To examine the role of NKT cells in the development of uveitis, EAU was elicited by immunization with a peptide from the human interphotoreceptor retinoid-binding protein (hIRBP1-20) in complete Freund's adjuvant and histopathology scores were evaluated in C57BL/6 (WT) and NKT cell-deficient mice. NKT cell-deficient mice developed more severe EAU pathology than WT mice. When WT mice were treated with ligands of the invariant subset of NKT cells (α-GalCer or RCAI-56), EAU was ameliorated in mice treated with RCAI-56 but not α-GalCer. IRBP-specific Th1/Th17 cytokines were reduced in RCAI-56-treated compared with vehicle-treated mice. Although the numbers of IRBP-specific T cells detected by hIRBP3-13/I-Ab tetramers in the spleen and the draining lymph node were the same for vehicle and RCAI-56 treatment groups, RORγt expression by tetramer-positive cells in RCAI-56-treated mice was lower than in control mice. Moreover, the eyes of RCAI-56-treated mice contained fewer IRBP-specific T cells compared with control mice. These results suggest that invariant NKT (iNKT) cells suppress the induction of Th17 cells and infiltration of IRBP-specific T cells into the eyes, thereby reducing ocular inflammation. However, in sharp contrast to the ameliorating effects of iNKT cell activation during the initiation phase of EAU, iNKT cell activation during the effector phase exacerbated disease pathology. Thus, we conclude that iNKT cells exhibit dual roles in the development of EAU.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D012173 Retinitis Inflammation of the RETINA. It is rarely limited to the retina, but is commonly associated with diseases of the choroid (CHORIORETINITIS) and of the OPTIC DISK (neuroretinitis). Neuroretinitis
D014605 Uveitis Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed) Uveitides
D015551 Autoimmunity Process whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES. Autoimmune Response,Autoimmune Responses,Autoimmunities

Related Publications

Masashi Satoh, and Ken-Ichi Namba, and Nobuyoshi Kitaichi, and Noriko Endo, and Hirokuni Kitamei, and Daiju Iwata, and Shigeaki Ohno, and Susumu Ishida, and Kazunori Onoé, and Hiroshi Watarai, and Masaru Taniguchi, and Tatsuro Ishibashi, and Joan Stein-Streilein, and Koh-Hei Sonoda, and Luc Van Kaer, and Kazuya Iwabuchi
February 2021, Experimental eye research,
Masashi Satoh, and Ken-Ichi Namba, and Nobuyoshi Kitaichi, and Noriko Endo, and Hirokuni Kitamei, and Daiju Iwata, and Shigeaki Ohno, and Susumu Ishida, and Kazunori Onoé, and Hiroshi Watarai, and Masaru Taniguchi, and Tatsuro Ishibashi, and Joan Stein-Streilein, and Koh-Hei Sonoda, and Luc Van Kaer, and Kazuya Iwabuchi
February 2012, The Proceedings of the Nutrition Society,
Masashi Satoh, and Ken-Ichi Namba, and Nobuyoshi Kitaichi, and Noriko Endo, and Hirokuni Kitamei, and Daiju Iwata, and Shigeaki Ohno, and Susumu Ishida, and Kazunori Onoé, and Hiroshi Watarai, and Masaru Taniguchi, and Tatsuro Ishibashi, and Joan Stein-Streilein, and Koh-Hei Sonoda, and Luc Van Kaer, and Kazuya Iwabuchi
April 2016, Current opinion in immunology,
Masashi Satoh, and Ken-Ichi Namba, and Nobuyoshi Kitaichi, and Noriko Endo, and Hirokuni Kitamei, and Daiju Iwata, and Shigeaki Ohno, and Susumu Ishida, and Kazunori Onoé, and Hiroshi Watarai, and Masaru Taniguchi, and Tatsuro Ishibashi, and Joan Stein-Streilein, and Koh-Hei Sonoda, and Luc Van Kaer, and Kazuya Iwabuchi
July 2014, Immunology,
Masashi Satoh, and Ken-Ichi Namba, and Nobuyoshi Kitaichi, and Noriko Endo, and Hirokuni Kitamei, and Daiju Iwata, and Shigeaki Ohno, and Susumu Ishida, and Kazunori Onoé, and Hiroshi Watarai, and Masaru Taniguchi, and Tatsuro Ishibashi, and Joan Stein-Streilein, and Koh-Hei Sonoda, and Luc Van Kaer, and Kazuya Iwabuchi
November 2023, Autoimmunity reviews,
Masashi Satoh, and Ken-Ichi Namba, and Nobuyoshi Kitaichi, and Noriko Endo, and Hirokuni Kitamei, and Daiju Iwata, and Shigeaki Ohno, and Susumu Ishida, and Kazunori Onoé, and Hiroshi Watarai, and Masaru Taniguchi, and Tatsuro Ishibashi, and Joan Stein-Streilein, and Koh-Hei Sonoda, and Luc Van Kaer, and Kazuya Iwabuchi
October 2008, Proceedings of the National Academy of Sciences of the United States of America,
Masashi Satoh, and Ken-Ichi Namba, and Nobuyoshi Kitaichi, and Noriko Endo, and Hirokuni Kitamei, and Daiju Iwata, and Shigeaki Ohno, and Susumu Ishida, and Kazunori Onoé, and Hiroshi Watarai, and Masaru Taniguchi, and Tatsuro Ishibashi, and Joan Stein-Streilein, and Koh-Hei Sonoda, and Luc Van Kaer, and Kazuya Iwabuchi
January 2017, Frontiers in immunology,
Masashi Satoh, and Ken-Ichi Namba, and Nobuyoshi Kitaichi, and Noriko Endo, and Hirokuni Kitamei, and Daiju Iwata, and Shigeaki Ohno, and Susumu Ishida, and Kazunori Onoé, and Hiroshi Watarai, and Masaru Taniguchi, and Tatsuro Ishibashi, and Joan Stein-Streilein, and Koh-Hei Sonoda, and Luc Van Kaer, and Kazuya Iwabuchi
June 2006, The New England journal of medicine,
Masashi Satoh, and Ken-Ichi Namba, and Nobuyoshi Kitaichi, and Noriko Endo, and Hirokuni Kitamei, and Daiju Iwata, and Shigeaki Ohno, and Susumu Ishida, and Kazunori Onoé, and Hiroshi Watarai, and Masaru Taniguchi, and Tatsuro Ishibashi, and Joan Stein-Streilein, and Koh-Hei Sonoda, and Luc Van Kaer, and Kazuya Iwabuchi
June 2006, The New England journal of medicine,
Masashi Satoh, and Ken-Ichi Namba, and Nobuyoshi Kitaichi, and Noriko Endo, and Hirokuni Kitamei, and Daiju Iwata, and Shigeaki Ohno, and Susumu Ishida, and Kazunori Onoé, and Hiroshi Watarai, and Masaru Taniguchi, and Tatsuro Ishibashi, and Joan Stein-Streilein, and Koh-Hei Sonoda, and Luc Van Kaer, and Kazuya Iwabuchi
September 2023, Experimental & molecular medicine,
Copied contents to your clipboard!